ADRB2 agonists could treat PD

In a paper published in Science, researchers showed that adrenergic receptor beta 2 (ADRB2) agonists reduce alpha synuclein (SNCA) gene levels. The study suggests that ADRB2 agonists, which are approved to treat asthma, could be repurposed to treat Parkinson's disease.

The paper's authors include scientists from Brigham and Women's Hospital and Harvard Medical School...